GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pheton Holdings Ltd (NAS:PTHL) » Definitions » Operating Margin %

PTHL (Pheton Holdings) Operating Margin % : -142.38% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Pheton Holdings Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Pheton Holdings's Operating Income for the six months ended in Jun. 2024 was $-0.30 Mil. Pheton Holdings's Revenue for the six months ended in Jun. 2024 was $0.21 Mil. Therefore, Pheton Holdings's Operating Margin % for the quarter that ended in Jun. 2024 was -142.38%.

The historical rank and industry rank for Pheton Holdings's Operating Margin % or its related term are showing as below:

PTHL' s Operating Margin % Range Over the Past 10 Years
Min: -83.22   Med: 11.03   Max: 29.59
Current: -83.22


PTHL's Operating Margin % is ranked worse than
76.59% of 820 companies
in the Medical Devices & Instruments industry
Industry Median: 0.915 vs PTHL: -83.22

Pheton Holdings's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Pheton Holdings's Operating Income for the six months ended in Jun. 2024 was $-0.30 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.48 Mil.


Pheton Holdings Operating Margin % Historical Data

The historical data trend for Pheton Holdings's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pheton Holdings Operating Margin % Chart

Pheton Holdings Annual Data
Trend Dec21 Dec22 Dec23
Operating Margin %
29.59 11.03 -41.18

Pheton Holdings Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Operating Margin % Get a 7-Day Free Trial 20.67 -1.71 -30.71 -48.90 -142.38

Competitive Comparison of Pheton Holdings's Operating Margin %

For the Medical Devices subindustry, Pheton Holdings's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pheton Holdings's Operating Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pheton Holdings's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Pheton Holdings's Operating Margin % falls into.



Pheton Holdings Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Pheton Holdings's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=-0.259 / 0.629
=-41.18 %

Pheton Holdings's Operating Margin % for the quarter that ended in Jun. 2024 is calculated as

Operating Margin %=Operating Income (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=-0.299 / 0.21
=-142.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pheton Holdings  (NAS:PTHL) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Pheton Holdings Operating Margin % Related Terms

Thank you for viewing the detailed overview of Pheton Holdings's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pheton Holdings Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Hong Jun Ying South Road, Room 306, NET Building, Chaoyang District, Beijing, CHN, 100101
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

Pheton Holdings Headlines